Locations:
Search IconSearch

Pulmonary

Surfactant Replacement Therapy in ARDS
January 12, 2016/Pulmonary/Clinical Trial

Surfactant Replacement Therapy in ARDS

A rationale for future optimism

Bronchial Thermoplasty
January 11, 2016/Pulmonary

Cost Effectiveness of Bronchial Thermoplasty in Severe Uncontrolled Asthma

Patient population, costs determine practicality

Antibiotics Are a Common Cause of Perioperative Anaphylaxis
January 8, 2016/Pulmonary/News & Insight

Antibiotics Are a Common Cause of Perioperative Anaphylaxis

Exposure warrants scrutiny for surgical patients

U.S. map of boundaries of donation service areas and lung transplant centers
January 6, 2016/Pulmonary/Lung Transplant

Increasing Access to Lung Transplant Through Changes in Donor Lung Allocation

Efficient utilization and distribution benefits patients

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

COPD
December 4, 2015/Pulmonary/News & Insight

Clinical Phenotypes in COPD

An emerging paradigm

IPF-690×380
November 13, 2015/Pulmonary/Research

Promising Emerging Therapies for the Treatment of Idiopathic Pulmonary Fibrosis

Clinical trials necessary to cure devastating disorder

690×380-Kraynack

Combating Pediatric Cystic Fibrosis on All Fronts

Success lies in integrating peds subspecialists and adult providers

IPF-690×380
September 23, 2015/Pulmonary/News & Insight

Pirfenidone and Nintedanib: Novel Agents in the Treatment of Idiopathic Pulmonary Fibrosis

FDA-approved drugs offer hope for devastating lung disease

BackPage 35 of 37Next

Advertisement

Ad